Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDS (DELTA)

July 29, 2022 updated by: University Hospital, Angers

Comparison of Different Positive End-expiratory Pressure Titration Strategies Using ELectrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrome : the DELTA Physiological Study

The aim of the this study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit.

Two of those strategies are based on electrical impedance tomography (EIT) monitoring.

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49100
        • Chu Angers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with moderate to severe ARDS, defined by the Berlin consensus, at 12 to 48h from diagnosis
  • PaO2/FiO2 ratio < 150 mmHg
  • Patient affiliated to or beneficiary of a health care plan
  • Consent obtained from patient's SDM

Exclusion Criteria:

  • Pneumothorax
  • Contraindication to the insertion of a nasogastric tube with an esophageal balloon
  • Contraindication to the use of Electrical impedance tomography
  • Pregnancy, lactating or parturient woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A-B-A-C
Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B) - Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C)
Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)
Experimental: A-C-A-B
Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C) - Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B)
Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PaO2 (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance!
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PaCO2 (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Plateau pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Positive end expiratory pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Expiratory and inspiratory transpulmonary pressure (cmH2O)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Regional ventilation distribution (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Center of ventilation (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Overdistension and collapsus (%)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Global and regional end expiratory lung impedance changes (IU)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
End expiratory lung volume (mL)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Blood pressure (mmHg)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Heart rate (bpm)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
Cardiac output (L/min)
Time Frame: Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes
As it is a physiological study, all the outcomes will be analyzed with the same importance
Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 22, 2020

Primary Completion (Actual)

April 8, 2021

Study Completion (Actual)

April 8, 2021

Study Registration Dates

First Submitted

January 21, 2020

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 30, 2020

Study Record Updates

Last Update Posted (Actual)

August 2, 2022

Last Update Submitted That Met QC Criteria

July 29, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Lung Injury

Clinical Trials on Ventilation strategy

3
Subscribe